|
|
Correspondence on AHA Statements and Guidelines The AHA encourages correspondence on statements and guidelines. The AHA welcomes letters sent directly to us on statements and guidelines. The letters are brought to the attention of the Writing Committee chair/co-chairs. Any input that might have an impact on recommendations for patient care or patient safety will be considered immediately. Letters are also reviewed by the AHA Manuscript Oversight Committee. If a response is warranted, one will be sent and possibly posted on americanheart.org. Publication of any letters to the editor on statements and guidelines in AHA journals is the purview of the editor and not the AHA. Letters on AHA statements and guidelines can be sent to pubauth@heart.org. Letter to the Editor and writing group response: "Omega-6 Fatty Acids and Risk of Cardiovascular Disease" -- letters submitted by Ramsdale, Hibbeln, Lands, and Tribole Letter to the Editor and writing group response: "The Impact of Prevention on Reducing the Burden of Cardiovascular Disease" -- letter submitted by Williamson and Narayan Letter to the Editor and writing group response: "Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder" -- letter submitted by Chang Letter to the Editor and writing group response: "Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder" -- letter submitted by Van Hare, et al. Letter to the Editor and writing group response: "Prevention of Infective Endocarditis Guidelines from the American Heart Association" -- letter submitted by Ramsdale, et al. Letter to the Editor and writing group response: "Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians" -- letter submitted by Schnitzer, et al. Letter to the Editor and writing group response: "Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians" -- letter submitted by Colucci, et al. Letter to the Editor and writing group response: "Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians" -- letter submitted by Drs. Warner and Mitchell Letter to the Editor and writing group response:"Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians" -- letter submitted by American College of Rheumatology Letter to the Editor and writing group response: "Use of Nonsteroidal Antiinflammatory Drugs: An Update for Clinicians" -- letter submitted by Pfizer Letter to the Editor: Invasive Dental Surgery is safe in Patients Receiving Thienopyridines Alone or in Combination with Aspirin without Discontinuation of Antiplatelet Therapy Letter to the Editor and writing group response: "Influenza Vaccination as Secondary Prevention for Cardiovascular Disease" |
|
||||||||||||||||||||||||||||||||||||||||||||||||
| ||||